Why the gate exists
The sensors got good. The models got good. What nobody solved was who is accountable when the automation acts on a person.
Wearables have been producing clinically useful signal for a decade. The blocker was never resolution; it was that nobody wanted to own what happened next. A device that raises an alarm makes a clinician responsible for it. A device that acts on its own makes a vendor responsible for it. So most products do neither, and a great deal of signal goes into a chart nobody reads.
BioFlow takes the third option: the platform proposes, a named person disposes, and the record shows exactly what was known at the moment of the decision. That turns the awkward question of who is accountable into an answerable one.
It also makes automation adoptable in places that have refused it. A safety officer will not accept a system that stands people down on its own. They will accept one that puts a well-argued proposal in front of them in four seconds and logs their answer.
What we will not build
- Silent escalation. Every proposal names who it went to.
- Employer access to individual signal without the wearer approving it.
- Diagnostic claims. BioFlow raises proposals; clinicians diagnose.
- Pricing that rewards routing actions around the gate.
- Rules that cannot be replayed against the signal that fired them.
| Market | Size | Growth | What BioFlow takes from it |
|---|---|---|---|
| Wearable devices | $185B | - | The sensing layer, already on wrists and chests |
| Human-in-the-loop AI | $16.4B | 24.9% CAGR | The approval discipline buyers must now evidence |
| Remote patient monitoring | $56.9B | - | The first vertical with budget, workflow and regulation in place |
Roughly $275B combined, narrowing to about $38B once you keep only regulated settings that require an auditable human decision. Figures from the 2025-26 market study prepared for this programme.
Start with one ward, one shift, or one squad
A pilot runs four to sixteen weeks depending on deployment model. You bring the population and the responders. We bring devices, gateways and the first set of rules, and we measure override rate and time-to-answer from day one.